Anti-obesity medicine developed from seaweeds

“CadalminTM ACe can be administered to regulate clinical indicators leading to dyslipidemia or obesity, total adipose tissue and visceral fat, triglycerides, cholesterol – both good and bad,” Chakraborty said.
Dr Kajal Chakraborty, senior scientist in the CMFRI’s Marine Biotechnology division, who developed the product, said bioactive pharmacophore leads from seaweeds were used to prepare the nutraceutical product.

Indian marine scientists have developed a “natural remedy” from seaweeds for treating obesity and dyslipidemia, a Government-run marine research institute said on Wednesday.

The product – CadalminTM Antihypercholesterolemic extract (CadalminTM ACe) – is the only natural remedy of obesity and dyslipidemia made by 100 per cent natural marine bioactive ingredients from seaweeds, scientists at the Kochi-headquartered Central Marine Fisheries Research Institute say.

CMFRI scientists prepared the extract from seaweeds which are commonly available in Indian coastal waters and are known for their extraordinary medicinal properties, they said. Full Story

Be the first to comment

Leave a Reply

Your email address will not be published.